Dose finding study on arbekacin sulfate for appropriate peak levels

Japanese Journal of Chemotherapy

Volumn 59, Issue 6, 2011, Pages 598-604

  Kimura, Toshimi ^a   Sunakawa, Keisuke ^b   Totsuka, Kyoichi ^c   Matsumoto, Tetsuya ^d   Hanaki, Hideaki ^b   Soma, Kazui ^b   Suzuki, Yukio ^b   Yoshida, Minoru ^e   Otsuka, Yoshihito ^f   Nemoto, Manabu ^g   Yokota, Hiroyuki ^h   Higashihara, Masaaki ^b   Oda, Shigeto ⁱ   Akiyama, Nobu ^e   Miyao, Naoki ^j   Yukioka, Tetsuo ^d   Ohyashiki, Kazuma ^d   Arai, Takao ^d   Ikegami, Keiichi ^k   Ichiwata, Toshio ^d   Kobayashi, Masahiro ^l   more..

^a TOKYO WOMEN S MEDICAL UNIVERSITY MEDICAL CENTER EAST   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d TOKYO MEDICAL UNIVERSITY   (Japan)

^e TEIKYO UNIVERSITY   (Japan)

^f KAMEDA MEDICAL CENTER   (Japan)

^g SAITAMA MEDICAL UNIVERSITY   (Japan)

^h NIPPON MEDICAL SCHOOL   (Japan)

ⁱ CHIBA UNIVERSITY   (Japan)

^j NIPPON KOKAN HOSPITAL   (Japan)

^k DOKKYO MEDICAL UNIVERSITY   (Japan)

^l KITASATO UNIVERSITY HOSPITAL   (Japan)

more..

Author keywords

Arbekacin; Dosage regimen; Peak concentration; TDM

Indexed keywords

HABEKACIN;

ARTICLE; CLINICAL ARTICLE; DOSE CALCULATION; DOSE RESPONSE; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG ELIMINATION; HUMAN;

EID: 83255188692     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. rd ed. Lippincott Williams & Wilkins, Philadelphia 1994; 129-71
2. Scaglione F: Can PK/PD be used in everyday clinical practice. Int J Antimicrob Agents 2002; 19: 349-53
3. Sato R, Tanigawara Y, Kaku M, Aikawa N, Shimizu K: Pharmacokinetic- pharmacodynamic relationship of arbekacin for treatment of patients infected with methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2006; 50: 3763-9 (Pubitemid 44684891)
4. Murry K R, McKinnon P S, Mitrzyk B, Rybak M J: Pharmacodynamic characterization of nephrotoxicity associated with once-daily aminoglycoside. Pharmacotherapy 1999; 19: 1252-60